688278 logo

Xiamen Amoytop Biotech Co., Ltd. Stock Price

SHSE:688278 Community·CN¥29.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

688278 Share Price Performance

CN¥0
-80.62 (-100.00%)
CN¥0
-80.62 (-100.00%)
Price CN¥0

688278 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Exceptional growth potential with excellent balance sheet.

0 Risks
3 Rewards

Xiamen Amoytop Biotech Co., Ltd. Key Details

CN¥3.7b

Revenue

CN¥0

Cost of Revenue

CN¥3.7b

Gross Profit

CN¥2.7b

Other Expenses

CN¥1.0b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Mar 27, 2026
2.54
100.00%
28.08%
4.7%
View Full Analysis

About 688278

Founded
1996
Employees
2685
CEO
Li Sun
WebsiteView website
www.amoytop.com

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, such as pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.

Recent 688278 News & Updates

Recent updates

No updates